Medical Science Liaison Rare Diseases

- Scientific/clinical profile with a university degree in MD, Pharmacy, PhD, or a Bachelor's degree in Health Sciences.
- At least 4 years of experience as an MSL in areas of interest.
- Previous experience in rare diseases, genetics, hereditary metabolic diseases, or lysosomal diseases will be valued.

High level of English and native Spanish.

- The Lysosomal Diseases MSL is a key member in the development and execution of the medical and scientific objectives of the Rare Diseases Unit, actively contributing to the company's medical strategy across all phases of the product lifecycle.
- They drive scientific exchange, knowledge generation, and medical education in lysosomal pathologies, promoting a deep understanding of the needs of patients and the healthcare professionals involved in their care.
- They act as a regional and internal scientific reference for lysosomal diseases, establishing relationships of trust with experts, patient associations, and other key stakeholders in the rare disease ecosystem.
- They facilitate the connection between the company and the scientific community, promoting the generation of evidence and the continuous improvement of care for patients with lysosomal diseases.

- They act as a scientific and medical advisory reference in the territory for lysosomal diseases and assigned products, providing updated scientific information to healthcare professionals, researchers, and internal teams.
- They develop, maintain, and strengthen high-level scientific relationships with key specialists in areas such as genetics, internal medicine, neurology, nephrology, cardiology, hematology, metabolism, and pediatrics, among other disciplines involved in the diagnosis and treatment of lysosomal diseases.
- They identify relevant medical insights and develop a deep understanding of the healthcare ecosystem, diagnostic pathways, and the patient journey of patients with lysosomal diseases.
- They detect unmet needs of patients and healthcare professionals, identifying opportunities for scientific evidence generation, the development of collaborative projects, and value solutions that contribute to improving the diagnosis, management, and follow-up of these pathologies.
- They implement the national medical plan in the assigned regions, working cross-functionally with Medical Advisors, Market Access, Marketing, Sales, and other key functions to ensure the correct execution of the medical strategy.
- They participate in the identification, evaluation, and implementation of observational studies, patient registries, investigator-initiated studies (IIS), and national and international clinical trials, collaborating in site selection, conducting feasibilities, and monitoring recruitment and study execution.

- They promote high-value medical projects aimed at improving knowledge of lysosomal diseases, supporting early diagnosis, and optimizing the multidisciplinary approach to the patient.
- They collaborate on scientific publications, congress communications, advisory boards, scientific meetings, symposia, and other high-value medical initiatives.
- They manage the relationship with assigned KOLs, identifying new opinion leaders, emerging experts, and reference centers in lysosomal diseases.
- They respond to medical information requests made by healthcare professionals, ensuring compliance with internal procedures and alignment with the corresponding medical leads.
- They participate in training activities aimed at healthcare professionals and internal teams, contributing to the development of scientific knowledge regarding lysosomal diseases.
- They collaborate with national and regional scientific societies, identifying opportunities for collaboration and scientific dissemination.
- They maintain a close relationship with patient associations and rare disease organizations, identifying unmet needs and integrating them into the company's medical strategy.
- They contribute to the development and review of scientific materials, ensuring their rigor, clinical relevance, and alignment with the needs of the therapeutic area.
- They maintain updated knowledge of scientific advances, clinical guidelines, innovative therapies, and emerging trends in the field of lysosomal diseases and rare diseases.

Northern Zone
- Asturias
- Cantabria
- Basque Country
- Navarra
- La Rioja
- Aragón
- Catalonia
- Balearic Islands
- Valencian Community
- Murcia
- Eastern Andalusia (Granada, Almería, and Jaén)

- Business vision
- Synthesis capacity and effective scientific communication
- Impact and Influence
- Positive thinking and capacity for continuous learning
- Organization and scientific methodology
- Staying at the forefront of the sector and knowledge of trends and digital transformation in the healthcare environment
- Ability to interact with opinion leaders and with various internal and external stakeholders